The Efficacy of HGF/VEGF Gene Therapy for Limb Ischemia in Mice with Impaired Glucose Tolerance: Shift from Angiogenesis to Axonal Growth and Oxidative Potential in Skeletal Muscle
Background: Combined non-viral gene therapy (GT) of ischemia and cardiovascular disease is a promising tool for potential clinical translation. In previous studies our group has developed combined gene therapy by vascular endothelial growth factor 165 (<i>VEGF165</i>) + hepatocyte growth...
Main Authors: | Iurii S. Stafeev I, Maria A. Boldyreva, Svetlana S. Michurina, Margarita Yu. Agareva, Arina V. Radnaeva, Mikhail Yu. Menshikov, Yu-Chen Hu, Pavel I. Makarevich, Yelena V. Parfyonova |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2022-11-01
|
Series: | Cells |
Subjects: | |
Online Access: | https://www.mdpi.com/2073-4409/11/23/3824 |
Similar Items
-
Therapeutic Angiogenesis by a “Dynamic Duo”: Simultaneous Expression of HGF and VEGF165 by Novel Bicistronic Plasmid Restores Blood Flow in Ischemic Skeletal Muscle
by: Ekaterina Slobodkina, et al.
Published: (2020-12-01) -
Angiogenic and pleiotropic effects of VEGF165 and HGF combined gene therapy in a rat model of myocardial infarction.
by: Pavel I Makarevich, et al.
Published: (2018-01-01) -
Co-Expression of VEGF and FGF2 Mediated by Multigenic Plasmid Constructs Promotes Blood Flow Restoration in a Rat Model of Hind Limb Ischemia
by: Dilara Gatina, et al.
Published: (2022-11-01) -
The level of VEGF-A in the lacrimal fluid of diabetic retinopathy
by: Yu. A. Borzilova, et al.
Published: (2015-12-01) -
Transplantation of Adipose-Tissue-Engineered Constructs with CRISPR-Mediated UCP1 Activation
by: Svetlana Michurina, et al.
Published: (2023-02-01)